Abstract:Glycogen synthase kinase 3beta is reported to repress Wnt/beta-catenin pathway and regulate the balance between cellular proliferation and apoptosis. Its inactivation by ser(9) phosphorylation might play a critical role in the tumorigenesis and development of malignancies. Here, the expression of phosphorylated glycogen synthase kinase 3beta at ser(9) was examined in gastric carcinoma and adjacent non-neoplastic mucosa by immunohistochemistry and Western blot, and compared with the clinicopathological parameters of carcinomas, including the expression of vascular endothelial growth factor, extracellular matrix metalloproteinase inducer and beta-catenin, and microvessel density labeled by CD34, as well as survival data. Gastric carcinoma cell lines (MKN28, MKN45, AGS, GT-3 TKB, KATO-III and HGC-27) were studied for the phosphorylated kinase by Western blot and for its encoding mRNA by RT-PCR, followed by sequencing. All carcinoma cell lines showed strong expression of the phosphorylated kinase and its encoding mRNA.There were two isoforms of glycogen synthase kinase 3beta in all carcinoma cell lines and a synonymous mutation in HGC-27 carcinoma cell line at codon 65(GGA-->GGT: Gly). The phosphorylated kinase was localized in the cytoplasm of gastric carcinoma cell lines or carcinomas. It was more expressed in gastric carcinomas than that in non-neoplastic mucosa (P < .05) in line with the data of Western blot. There was a higher expression of the phosphorylated kinase in men carcinoma patients than that in women (P < .05). Its expression was positively correlated with depth of invasion, lymphatic and venous invasion, lymph node metastasis, Union Internationale le Contre Cancer staging, expression of vascular endothelial growth factor and extracellular matrix metalloproteinase inducer in gastric carcinoma (P < .05). Survival analysis indicated the phosphorylated kinase expression to be positively linked to poor prognosis (P< 05), but not independent (P>.05). Three independent prognostic factors, depth of invasion, lymphatic and venous invasion, concordantly influenced its relationship with prognosis (P < .05). Our study indicated that up-regulated expression of phosphorylated glycogen synthase kinase 3beta at ser(9) was closely linked to gastric carcinogenesis and subsequent progression, and could be employed as a good indicator of aggressive behaviors and prognosis of gastric carcinoma.

The Essential Role of TNIK Gene Amplification in Gastric Cancer Growth.

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Expression of Ngf Family and Their Receptors in Gastric Carcinoma: A Cdna Microarray Study

Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.

Expression and Function of Transforming Growth Factor-Β-activated Protein Kinase 1 in Gastric Cancer

Abstract 2818: Investigating the role of TNIK in the pathogenesis of lung squamous cell carcinoma

Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression

KNTC1 functions as a potential biomarker and oncogene regulating proliferation, migration and apoptosis in gastric cancer

NUAK1 activates STAT5/GLI1/SOX2 signaling to enhance cancer cell expansion and drives chemoresistance in gastric cancer

Tousled-like kinase 1 promotes gastric cancer progression by regulating the tumor growth factor-beta signaling pathway

[Clinicopathological Features of Gastric Carcinomas with NTRK-rearrangement/amplification: Report of Four Cases].

Exploring the effect of NK-cell related molecules on the prognosis and tumor microenvironment of gastric cancer patients: Evidence from large sample populations

Over-expressed and Truncated Midkines Promote Proliferation of BGC823 Cells in Vitro and Tumor Growth in Vivo.

TNFRSF11B activates Wnt/-catenin signaling and promotes gastric cancer progression

Involvement of Inactive GSK3β Overexpression in Tumorigenesis and Progression of Gastric Carcinomas

Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cells

Significant Gene Biomarker Tyrosine Kinase Non-receptor 2 Mediated Cell Proliferation and Invasion in Colon Cancer

China Special Issue on Gastrointestinal Tumors—ntrk Fusion in a Large Real‐world Population and Clinical Utility of Circulating Tumor DNA Genotyping to Guide TRK Inhibitor Treatment

Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing

MZT2A serves as a prognostic biomarker and promotes the progression of kidney renal clear cell carcinoma

KCND2: A prognostic biomarker and regulator of immune function in gastric cancer